Comparison of diagnostic value using a small, single channel, P-wave centric sternal ECG monitoring patch with a standard 3-lead Holter system over 24 hours

Smith, Warren; Riddell, F.; Madon, Morag; Gleva, Marye J.

doi:10.1016/j.ahj.2016.11.006

Cited by 50 publications

(31 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…After the administration of the drugs, atrial fibrillation (AF) was identified a few hours later, and a timely intervention by appropriate therapy for AF caused reversion to sinus rhythm. Similarly, the CAM™ Patch has been announced for use in monitoring QT interval in patients who have been treated with hydroxychloroquine [75,76]. Other ECG patch products with a similar function have been used in clinical studies including Zio XT (iRhythm, California, USA), NUVANT (Corventis, California, USA), Savvy monitor (Ljubljana, Slovenia) [77], and the SEEQ TM MCT patch (Medtronic, Inc) [78], VitalPatch wearable sensor (VitalConnect, California, USA) [79] (Fig.…”

Section: A Electrocardiogram For Monitoring Cvd and Covid-19 Patientsmentioning

confidence: 99%

Wearable Sensing and Telehealth Technology with Potential Applications in the Coronavirus Pandemic

Ding

Clifton

et al. 2021

IEEE Rev. Biomed. Eng.

218

155

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19) has emerged as a pandemic with serious clinical manifestations including death.A pandemic at the large-scale like COVID-19 places extraordinary demands on the world's health systems, dramatically devastates vulnerable populations, and critically threatens the global communities in an unprecedented way. While tremendous efforts at the frontline are placed on detecting the virus, providing treatments and developing vaccines, it is also critically important to examine the technologies and systems for tackling disease emergence, arresting its spread and especially the strategy for diseases prevention. The objective of this article is to review enabling technologies and systems with various application scenarios for handling the COVID-19 crisis. The article will focus specifically on 1) wearable devices suitable for monitoring the populations at risk and those in quarantine, both for evaluating the health status of caregivers and management personnel, and for facilitating triage processes for admission to hospitals; 2) unobtrusive sensing systems for detecting the disease and for monitoring patients with relatively mild symptoms whose clinical situation could suddenly worsen in improvised hospitals; and 3) telehealth technologies for the remote monitoring and diagnosis of COVID-19 and related diseases. Finally, further challenges and opportunities for future directions of development are highlighted.

show abstract

Section: A Electrocardiogram For Monitoring Cvd and Covid-19 Patientsmentioning

confidence: 99%

Wearable Sensing and Telehealth Technology with Potential Applications in the Coronavirus Pandemic

Ding

Clifton

et al. 2021

IEEE Rev. Biomed. Eng.

218

155

View full text Add to dashboard Cite

show abstract

“…A study using Carnation Ambulatory Monitor (CAM), a single channel ambulatory patch ECG monitor, designed specifically to ensure that the P wave component of the ECG be visible, showed a significantly improved rhythm diagnosis and avoided inaccurate diagnoses made by the standard 3 channel Holter monitor. 4 The maximum heart rate, minimum heart rate and the longest RR interval during the 24 hour period were better identified in the WebCardio system, though the difference was not statistically significant. These events are generated by the proprietary analysing algorithm for the AECG system.…”

Section: Discussionmentioning

confidence: 85%

Comparison of Quality of Ambulatory Electrocardiograms Obtained Using Novel Wireless ‘Android App’ Based Webcardio System and Conventional Holter

Prabhakaran¹,

Mathew²

2019

jebmh

View full text Add to dashboard Cite

BACKGROUND Ambulatory electrocardiogram (AECG) is done when cardiac arrhythmia is suspected. The conventional method of AECG recording uses 24 hour Holter. WebCardio using WiPatch is a new AECG system which can record for 72 hours. Since it is new and the WiPatch is placed in the left upper part of chest, the quality of the ECG especially that of P wave needs to be evaluated. METHODS The study compared the quality of AECG of wireless Android App based WebCardio system with the AECG of conventional Holter by simultaneously connecting both for 24 hours in patients having indication for AECG. The study was done in the department of cardiology, Medical College, Thrissur. The quality of P and QRS were compared at specific time periods of AECG, in the events and arrhythmias picked by AECG system and by scanning the entire AECG page by page. Periods of artefacts and no recording were evaluated. System generated events, maximum heart rate, minimum heart rate and longest RR interval were compared in both recordings. RESULTS 141 patients had simultaneous recordings by both systems of AECG. Overall quality of AECG was better with the WebCardio compared to Holter (138 Vs 125, p=0.001). Quality of P wave was better in the WebCardio than Holter (135 Vs 122, p=0.002) whereas quality of QRS was similar. The occurrence of artefacts lasting for more than 30 seconds was more in Holter compared to WebCardio (40 Vs 26, p=0.065), and no-recording lasting for more than 30 seconds were similar in the Holter and WebCardio (11 vs. 13). The maximum heart rate, minimum heart rate and longest RR interval were correctly identified in higher number of cases by WebCardio than the Holter (136 vs. 131, 139 vs. 138, 137 vs. 133 respectively), though statistically not different. CONCLUSIONS The study showed that the overall quality of 24 hour AECG recording was better in the WebCardio compared to Holter. This difference was due to the better quality of P in the WebCardio. Ambulatory ECG with WebCardio systems is a good alternative to conventional Holter.

show abstract

“…Moreover, conventional looping external event recorders are cumbersome and interfere with showering, sports, and other daily life activities, resulting in poor patient compliance and reduced diagnostic yield [4]. Adhesive cardiac monitor patches are characterized by ease-of-use, increased wearing comfort, and allow showering [15], but have limited recording durations (7–30 days) compared to conventional external loop recorders or implantable cardiac monitors [4,16,17] This study was intentionally limited to a recording period of 24 h, but the built-in capacity of signal transmission from the garment into a web based cloud provides already the technical basis for long-term monitoring, which will be studied in an upcoming multicenter trial. Also, the signal quality of the garments remains stable over prolonged recording periods, including washing (unpublished results), whereas there are some concerns about decreased signal quality and loss of automated rhythm analysis in adhesive monitor patches [18].…”

Section: Discussionmentioning

confidence: 99%

A Novel Wearable Device for Continuous Ambulatory ECG Recording: Proof of Concept and Assessment of Signal Quality

et al. 2019

View full text Add to dashboard Cite

Diagnosis of arrhythmic disorders is challenging because of their short-lasting, intermittent character. Conventional technologies of noninvasive ambulatory rhythm monitoring are limited by modest sensitivity. We present a novel form of wearable electrocardiogram (ECG) sensors providing an alternative tool for long-term rhythm monitoring with the potential of increased sensitivity to detect intermittent or subclinical arrhythmia. The objective was to assess the signal quality and R-R coverage of a wearable ECG sensor system compared to a standard 3-lead Holter. In this phase-1 trial, healthy individuals underwent 24-h simultaneous rhythm monitoring using the OMsignal system together with a 3-lead Holter recording. The OMsignal system consists of a garment (bra or shirt) with integrated sensors recording a single-lead ECG and an acquisition module for data storage and processing. Head-to-head signal quality was assessed regarding adequate P-QRS-T distinction and was performed by three electrophysiologists blinded to the recording technology. The accuracy of signal coverage was assessed using Bland-Altman analysis. Fifteen individuals underwent simultaneous 24-h recording. Signal quality and accuracy of the OMgaments was equivalent to Holter-monitoring (84% vs 93% electrophysiologists rating, p = 0.06). Signal coverage of R-R intervals showed a very close overlay between the OMsignal system and Holter signals, mean difference in heart rate of 2 5 bpm. The noise level of OMgarments was comparable to Holter recording. OMgarments provide high signal quality for adequate rhythm analysis, representing a promising novel technology for long-term non-invasive ECG monitoring.

show abstract

Comparison of diagnostic value using a small, single channel, P-wave centric sternal ECG monitoring patch with a standard 3-lead Holter system over 24 hours

Cited by 50 publications

References 11 publications

Wearable Sensing and Telehealth Technology with Potential Applications in the Coronavirus Pandemic

Wearable Sensing and Telehealth Technology with Potential Applications in the Coronavirus Pandemic

Comparison of Quality of Ambulatory Electrocardiograms Obtained Using Novel Wireless ‘Android App’ Based Webcardio System and Conventional Holter

A Novel Wearable Device for Continuous Ambulatory ECG Recording: Proof of Concept and Assessment of Signal Quality

Contact Info

Product

Resources

About